LRP6: Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
|||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Low-density lipoprotein receptor-related protein 6''' is a [[protein]] that in humans is encoded by the ''LRP6'' [[gene]].<ref name="pmid9704021">{{cite journal |vauthors=Brown SD, Twells RC, Hey PJ, Cox RD, Levy ER, Soderman AR, Metzker ML, Caskey CT, Todd JA, Hess JF |title=Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family |journal=Biochem. Biophys. Res. Commun. |volume=248 |issue=3 |pages=879–88 |year=1998 |pmid=9704021 |doi=10.1006/bbrc.1998.9061}}</ref><ref name="entrez">{{cite web | title = Entrez Gene: LRP6 low density lipoprotein receptor-related protein 6| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4040}}</ref> LRP6 is a key component of the [[LRP5]]/LRP6/[[Frizzled]] co-receptor group that is involved in [[Wnt signaling pathway#The canonical Wnt pathway|canonical Wnt pathway]]. | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
==Structure== | |||
LRP6 is a transmembrane low-density [[lipoprotein]] [[receptor (biochemistry)|receptor]] that shares a similar structure with [[LRP5]]. In each protein, about 85% of its 1600-[[amino acid|amino-acid]] length is extracellular. Each has four β-propeller motifs at the amino terminal end that alternate with four [[epidermal growth factor]] (EGF)-like repeats. Most extracellular ligands bind to LRP5 and LRP6 at the β-propellers. Each protein has a single-pass, 22-amino-acid segment that crosses the cell membrane and a 207-amino-acid segment that is internal to the cell.<ref name="Williams">{{cite journal |vauthors=Williams BO, Insogna KL |title=Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone |journal=J. Bone Miner. Res. |volume=24 |issue=2 |pages=171–8 |year=2009 |pmid=19072724 |pmc=3276354 |doi=10.1359/jbmr.081235 |url=}}</ref> | |||
< | ==Function== | ||
{{ | LRP6 acts as a co-receptor with LRP5 and the [[Frizzled]] protein family members for transducing signals by [[Wnt signaling pathway|Wnt]] proteins through the [[Wnt signaling pathway#The canonical Wnt pathway|canonical Wnt pathway]].<ref name="Williams"/> | ||
| | |||
| | ==Interactions== | ||
}} | Canonical [[Wnt signaling pathway|WNT signals]] are transduced through [[Frizzled]] receptor and LRP5/LRP6 coreceptor to downregulate GSK3beta ([[GSK3B]]) activity not depending on Ser-9 [[phosphorylation]].<ref name="pmid16940750">{{cite journal |vauthors=Katoh M, Katoh M |title=Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades |journal=Cancer Biol. Ther. |volume=5 |issue=9 |pages=1059–64 |year=2006 |pmid=16940750 |doi=10.4161/cbt.5.9.3151}}</ref> Reduction of canonical Wnt signals upon depletion of LRP5 and LRP6 results in p120-[[catenin]] degradation.<ref name="Hong">{{cite journal |vauthors=Hong JY, Park JI, Cho K, Gu D, Ji H, Artandi SE, McCrea PD |title=Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members |journal=J. Cell Sci. |volume=123 |issue=Pt 24 |pages=4351–65 |year=2010 |pmid=21098636 |pmc=2995616 |doi=10.1242/jcs.067199 |url=}}</ref> | ||
LRP6 is regulated by extracellular proteins in the Dickkopf (Dkk) family (like [[DKK1]]<ref name="Semenov">{{cite journal |vauthors=Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S, He X |title=Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 |journal=Curr. Biol. |volume=11 |issue=12 |pages=951–61 |year=2001 |pmid=11448771 |doi= 10.1016/s0960-9822(01)00290-1|url=}}</ref>), [[sclerostin]], R-spondins and members of the cysteine-knot-type protein family.<ref name="Williams"/> | |||
==Clinical significance== | |||
Loss-of-function mutations or LRP6 in humans lead to increased plasma LDL and triglycerides, hypertension, diabetes and osteoporosis.<ref name="Williams"/> Similarly, mice with a loss-of-function Lrp6 mutation have low bone mass.<ref name="Kang"/> LRP6 is critical in bone's [[anabolic]] response to [[parathyroid hormone]] (PTH) treatment, whereas LRP5 is not involved.<ref name="Kang">{{cite journal |vauthors=Kang KS, Robling AG |title=New Insights into Wnt-Lrp5/6-β-Catenin Signaling in Mechanotransduction |journal=Front Endocrinol (Lausanne) |volume=5 |issue= |pages=246 |year=2014 |pmid=25653639 |pmc=4299511 |doi=10.3389/fendo.2014.00246 |url=}}</ref> On the other hand, LRP6 does not appear active in [[mechanotransduction]] (bone's response to forces), while LRP5 is critical in that role.<ref name="Kang"/> | |||
Sclerostin, one of the inhibitors of LRP6, is a promising osteocyte-specific Wnt antagonist in osteoporosis clinical trials.<ref name="Baron">{{Cite journal | vauthors = Baron R, Kneissel M| title = WNT signaling in bone homeostasis and disease: from human mutations to treatments | journal = Nature Medicine | volume = 19 | issue = 2 | pages = 179–192 |date=February 2013 | doi = 10.1038/nm.3074 | pmid = 23389618}}</ref><ref>{{Cite journal | vauthors = Burgers TA, Williams BO | title = Regulation of Wnt/beta-catenin signaling within and from osteocytes | journal = Bone | volume = 54 | issue = 2 | pages = 244–249 |date=June 2013 | doi = 10.1016/j.bone.2013.02.022 | pmid = 23470835 | pmc=3652284}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal | vauthors =He X, Semenov M, Tamai K, Zeng X |title=LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. |journal=Development |volume=131 |issue= 8 |pages= 1663–77 |year= 2004 |pmid= 15084453 |doi= 10.1242/dev.01117 }} | |||
*{{cite journal |vauthors=Hillier LD, Lennon G, Becker M, etal |title=Generation and analysis of 280,000 human expressed sequence tags. |journal=Genome Res. |volume=6 |issue= 9 |pages= 807–28 |year= 1997 |pmid= 8889549 |doi=10.1101/gr.6.9.807 }} | |||
*{{cite journal | | *{{cite journal |vauthors=Baens M, Wlodarska I, Corveleyn A, etal |title=A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). |journal=Genomics |volume=56 |issue= 1 |pages= 40–50 |year= 1999 |pmid= 10036184 |doi= 10.1006/geno.1998.5685 }} | ||
*{{cite journal | *{{cite journal |vauthors=Tamai K, Semenov M, Kato Y, etal |title=LDL-receptor-related proteins in Wnt signal transduction. |journal=Nature |volume=407 |issue= 6803 |pages= 530–5 |year= 2000 |pmid= 11029007 |doi= 10.1038/35035117 }} | ||
*{{cite journal | *{{cite journal |vauthors=Mao B, Wu W, Li Y, etal |title=LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. |journal=Nature |volume=411 |issue= 6835 |pages= 321–5 |year= 2001 |pmid= 11357136 |doi= 10.1038/35077108 }} | ||
*{{cite journal | *{{cite journal |vauthors=Semënov MV, Tamai K, Brott BK, etal |title=Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. |journal=Curr. Biol. |volume=11 |issue= 12 |pages= 951–61 |year= 2001 |pmid= 11448771 |doi=10.1016/S0960-9822(01)00290-1 }} | ||
*{{cite journal | *{{cite journal |vauthors=Li L, Mao J, Sun L, etal |title=Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. |journal=J. Biol. Chem. |volume=277 |issue= 8 |pages= 5977–81 |year= 2002 |pmid= 11742004 |doi= 10.1074/jbc.M111131200 }} | ||
*{{cite journal | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }} | ||
*{{cite journal | *{{cite journal |vauthors=Caricasole A, Ferraro T, Iacovelli L, etal |title=Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. |journal=J. Biol. Chem. |volume=278 |issue= 39 |pages= 37024–31 |year= 2003 |pmid= 12857724 |doi= 10.1074/jbc.M300191200 }} | ||
*{{cite journal | *{{cite journal | vauthors =Liu G, Bafico A, Harris VK, Aaronson SA |title=A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. |journal=Mol. Cell. Biol. |volume=23 |issue= 16 |pages= 5825–35 |year= 2003 |pmid= 12897152 |doi=10.1128/MCB.23.16.5825-5835.2003 | pmc=166321 }} | ||
*{{cite journal | | *{{cite journal | vauthors =Zilberberg A, Yaniv A, Gazit A |title=The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. |journal=J. Biol. Chem. |volume=279 |issue= 17 |pages= 17535–42 |year= 2004 |pmid= 14739301 |doi= 10.1074/jbc.M311292200 }} | ||
*{{cite journal | | *{{cite journal | vauthors =Wang X, Adhikari N, Li Q, Hall JL |title=LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. |journal=Am. J. Physiol. Heart Circ. Physiol. |volume=287 |issue= 6 |pages= H2376–83 |year= 2005 |pmid= 15271658 |doi= 10.1152/ajpheart.01173.2003 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Suzuki Y, Yamashita R, Shirota M, etal |title=Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. |journal=Genome Res. |volume=14 |issue= 9 |pages= 1711–8 |year= 2004 |pmid= 15342556 |doi= 10.1101/gr.2435604 | pmc=515316 }} | ||
*{{cite journal | *{{cite journal |vauthors=Gerhard DS, Wagner L, Feingold EA, etal |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 }} | ||
*{{cite journal | *{{cite journal |vauthors=Li Y, Lu W, He X, etal |title=LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. |journal=Oncogene |volume=23 |issue= 56 |pages= 9129–35 |year= 2005 |pmid= 15516984 |doi= 10.1038/sj.onc.1208123 }} | ||
*{{cite journal | vauthors =Semënov M, Tamai K, He X |title=SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. |journal=J. Biol. Chem. |volume=280 |issue= 29 |pages= 26770–5 |year= 2005 |pmid= 15908424 |doi= 10.1074/jbc.M504308200 }} | |||
*{{cite journal |vauthors=Li Y, Chen J, Lu W, etal |title=Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. |journal=J. Cell Sci. |volume=118 |issue= Pt 22 |pages= 5305–14 |year= 2006 |pmid= 16263759 |doi= 10.1242/jcs.02651 }} | |||
*{{cite journal | *{{cite journal | vauthors =Mi K, Dolan PJ, Johnson GV |title=The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. |journal=J. Biol. Chem. |volume=281 |issue= 8 |pages= 4787–94 |year= 2006 |pmid= 16365045 |doi= 10.1074/jbc.M508657200 }} | ||
*{{cite journal | | |||
*{{cite journal | |||
*{{cite journal | | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | {{Lipoprotein metabolism}} | ||
{{ | |||
{{gene-12-stub}} |
Latest revision as of 20:13, 8 November 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Low-density lipoprotein receptor-related protein 6 is a protein that in humans is encoded by the LRP6 gene.[1][2] LRP6 is a key component of the LRP5/LRP6/Frizzled co-receptor group that is involved in canonical Wnt pathway.
Structure
LRP6 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP5. In each protein, about 85% of its 1600-amino-acid length is extracellular. Each has four β-propeller motifs at the amino terminal end that alternate with four epidermal growth factor (EGF)-like repeats. Most extracellular ligands bind to LRP5 and LRP6 at the β-propellers. Each protein has a single-pass, 22-amino-acid segment that crosses the cell membrane and a 207-amino-acid segment that is internal to the cell.[3]
Function
LRP6 acts as a co-receptor with LRP5 and the Frizzled protein family members for transducing signals by Wnt proteins through the canonical Wnt pathway.[3]
Interactions
Canonical WNT signals are transduced through Frizzled receptor and LRP5/LRP6 coreceptor to downregulate GSK3beta (GSK3B) activity not depending on Ser-9 phosphorylation.[4] Reduction of canonical Wnt signals upon depletion of LRP5 and LRP6 results in p120-catenin degradation.[5]
LRP6 is regulated by extracellular proteins in the Dickkopf (Dkk) family (like DKK1[6]), sclerostin, R-spondins and members of the cysteine-knot-type protein family.[3]
Clinical significance
Loss-of-function mutations or LRP6 in humans lead to increased plasma LDL and triglycerides, hypertension, diabetes and osteoporosis.[3] Similarly, mice with a loss-of-function Lrp6 mutation have low bone mass.[7] LRP6 is critical in bone's anabolic response to parathyroid hormone (PTH) treatment, whereas LRP5 is not involved.[7] On the other hand, LRP6 does not appear active in mechanotransduction (bone's response to forces), while LRP5 is critical in that role.[7] Sclerostin, one of the inhibitors of LRP6, is a promising osteocyte-specific Wnt antagonist in osteoporosis clinical trials.[8][9]
References
- ↑ Brown SD, Twells RC, Hey PJ, Cox RD, Levy ER, Soderman AR, Metzker ML, Caskey CT, Todd JA, Hess JF (1998). "Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family". Biochem. Biophys. Res. Commun. 248 (3): 879–88. doi:10.1006/bbrc.1998.9061. PMID 9704021.
- ↑ "Entrez Gene: LRP6 low density lipoprotein receptor-related protein 6".
- ↑ 3.0 3.1 3.2 3.3 Williams BO, Insogna KL (2009). "Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone". J. Bone Miner. Res. 24 (2): 171–8. doi:10.1359/jbmr.081235. PMC 3276354. PMID 19072724.
- ↑ Katoh M, Katoh M (2006). "Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades". Cancer Biol. Ther. 5 (9): 1059–64. doi:10.4161/cbt.5.9.3151. PMID 16940750.
- ↑ Hong JY, Park JI, Cho K, Gu D, Ji H, Artandi SE, McCrea PD (2010). "Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members". J. Cell Sci. 123 (Pt 24): 4351–65. doi:10.1242/jcs.067199. PMC 2995616. PMID 21098636.
- ↑ Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S, He X (2001). "Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6". Curr. Biol. 11 (12): 951–61. doi:10.1016/s0960-9822(01)00290-1. PMID 11448771.
- ↑ 7.0 7.1 7.2 Kang KS, Robling AG (2014). "New Insights into Wnt-Lrp5/6-β-Catenin Signaling in Mechanotransduction". Front Endocrinol (Lausanne). 5: 246. doi:10.3389/fendo.2014.00246. PMC 4299511. PMID 25653639.
- ↑ Baron R, Kneissel M (February 2013). "WNT signaling in bone homeostasis and disease: from human mutations to treatments". Nature Medicine. 19 (2): 179–192. doi:10.1038/nm.3074. PMID 23389618.
- ↑ Burgers TA, Williams BO (June 2013). "Regulation of Wnt/beta-catenin signaling within and from osteocytes". Bone. 54 (2): 244–249. doi:10.1016/j.bone.2013.02.022. PMC 3652284. PMID 23470835.
Further reading
- He X, Semenov M, Tamai K, Zeng X (2004). "LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way". Development. 131 (8): 1663–77. doi:10.1242/dev.01117. PMID 15084453.
- Hillier LD, Lennon G, Becker M, et al. (1997). "Generation and analysis of 280,000 human expressed sequence tags". Genome Res. 6 (9): 807–28. doi:10.1101/gr.6.9.807. PMID 8889549.
- Baens M, Wlodarska I, Corveleyn A, et al. (1999). "A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p)". Genomics. 56 (1): 40–50. doi:10.1006/geno.1998.5685. PMID 10036184.
- Tamai K, Semenov M, Kato Y, et al. (2000). "LDL-receptor-related proteins in Wnt signal transduction". Nature. 407 (6803): 530–5. doi:10.1038/35035117. PMID 11029007.
- Mao B, Wu W, Li Y, et al. (2001). "LDL-receptor-related protein 6 is a receptor for Dickkopf proteins". Nature. 411 (6835): 321–5. doi:10.1038/35077108. PMID 11357136.
- Semënov MV, Tamai K, Brott BK, et al. (2001). "Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6". Curr. Biol. 11 (12): 951–61. doi:10.1016/S0960-9822(01)00290-1. PMID 11448771.
- Li L, Mao J, Sun L, et al. (2002). "Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled". J. Biol. Chem. 277 (8): 5977–81. doi:10.1074/jbc.M111131200. PMID 11742004.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Caricasole A, Ferraro T, Iacovelli L, et al. (2003). "Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins". J. Biol. Chem. 278 (39): 37024–31. doi:10.1074/jbc.M300191200. PMID 12857724.
- Liu G, Bafico A, Harris VK, Aaronson SA (2003). "A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor". Mol. Cell. Biol. 23 (16): 5825–35. doi:10.1128/MCB.23.16.5825-5835.2003. PMC 166321. PMID 12897152.
- Zilberberg A, Yaniv A, Gazit A (2004). "The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway". J. Biol. Chem. 279 (17): 17535–42. doi:10.1074/jbc.M311292200. PMID 14739301.
- Wang X, Adhikari N, Li Q, Hall JL (2005). "LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells". Am. J. Physiol. Heart Circ. Physiol. 287 (6): H2376–83. doi:10.1152/ajpheart.01173.2003. PMID 15271658.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions". Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Li Y, Lu W, He X, et al. (2005). "LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution". Oncogene. 23 (56): 9129–35. doi:10.1038/sj.onc.1208123. PMID 15516984.
- Semënov M, Tamai K, He X (2005). "SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor". J. Biol. Chem. 280 (29): 26770–5. doi:10.1074/jbc.M504308200. PMID 15908424.
- Li Y, Chen J, Lu W, et al. (2006). "Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding". J. Cell Sci. 118 (Pt 22): 5305–14. doi:10.1242/jcs.02651. PMID 16263759.
- Mi K, Dolan PJ, Johnson GV (2006). "The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity". J. Biol. Chem. 281 (8): 4787–94. doi:10.1074/jbc.M508657200. PMID 16365045.
This article on a gene on human chromosome 12 is a stub. You can help Wikipedia by expanding it. |